Folic acid-containing compound metabolic process

pathway activity — cross-omics
GO:0006760Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Folic acid-containing compound metabolic process pathway is significantly associated with the protein abundance of multiple proteins, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are TRIP13, CDC20_T70, and XPO5, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Folic acid-containing compound metabolic process activity versus TRIP13 in LUAD (Pearson r = 0.28).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADTRIP13 →+0.713+0.045<.001<.00137
OVCDC20_T70 →+0.903+0.044.002.00137
LSCCXPO5 →+0.413+0.032.002.00437
UCECRRM2 →+0.771+0.056<.001<.00136
OVTPX2_S486 →+0.737+0.034<.001<.00136
OVCDK1 →+0.751+0.047<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0006760 vs TRIP13 — LUAD

Per-sample scatter of Folic acid-containing compound metabolic process activity vs TRIP13 in LUAD.

Explore this scatter interactively →

Exploration